click below
click below
Normal Size Small Size show me how
alzheimer disease
ch 17 nervous system
Question | Answer |
---|---|
Alzheimer disease | progressive condition associated with memory loss, confusion, impaired judgment, personality changes, disorientation, and loss of language skills |
FDA approved two classes for AD | cholinesterase inhibitors and n-methyl-D-aspartate (NMDA) receptor agonists |
Aricept | donepezil *cholinesterase inhibitors |
Razadyne | galantamine *cholinesterase inhibitors |
Exelon | rivastigmine *cholinesterase inhibitors |
Namenda | memantine *NMDA receptor agonists |